Adalimumab for Moderately to Severely Active Ulcerative Colitis: A Systematic Review and Meta-Analysis

Xinlin Chen(Zhejiang University), Fengbin Liu(First Affiliated Hospital of Guangzhou University of Chinese Medicine), Zhengkun Hou(First Affiliated Hospital of Guangzhou University of Chinese Medicine), Chuan-wei Mo(Guangzhou University of Chinese Medicine), Yujie Yuan(University of Illinois Urbana-Champaign), Tianwen Liu(Guangzhou University of Chinese Medicine), Chaoyuan Huang(National Taiwan University Hospital), Jiangtao Hou(First Affiliated Hospital of Guangzhou University of Chinese Medicine), Weiling He(Sun Yat-sen University), Qian Xu(National Institute of Public Health), Haiwen Li(Sun Yat-sen University), Bin Chen(Southwest University)
BioDrugs
April 27, 2016
Cited by 13


Related Papers